Pain management principles in the critically ill

Chest

Volumn 135, Issue 4, 2009, Pages 1075-1086

  Erstad, Brian L ^a   Puntillo, Kathleen ^b   Gilbert, Hugh C ^c   Grap, Mary Jo ^d   Li, Denise ^e   Medina, Justine ^f   Mularski, Richard A ^g   Pasero, Chris ^h   Varkey, Basil ⁱ   Sessler, Curtis N ^j  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^e CALIFORNIA STATE UNIVERSITY   (United States)

^f American Association of Critical Care Nurses   (United States)

^g OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^h Pain Management Educator and Clinical Consultant   (United States)

ⁱ MEDICAL COLLEGE OF WISCONSIN   (United States)

^j VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

more..

Author keywords

Analgesics; Critical care; Nonpharmacologic interventions; Opioid; Pain

Indexed keywords

BACLOFEN; BENZODIAZEPINE; DEXMEDETOMIDINE; FENTANYL; GABAPENTIN; HALOPERIDOL; HYDROMORPHONE; LIDOCAINE; LORAZEPAM; METHADONE; MIDAZOLAM; MORPHINE; MU OPIATE RECEPTOR ANTAGONIST; NALOXONE; NORPETHIDINE; OPIATE; PETHIDINE; PILOCARPINE; REMIFENTANIL; UNINDEXED DRUG; VALPROIC ACID; NARCOTIC ANALGESIC AGENT;

ALLERGY; BRADYCARDIA; BRAIN TOXICITY; BRONCHOSPASM; CENTRAL NERVOUS SYSTEM DEPRESSION; CLINICAL TRIAL; COMA; CONSTIPATION; CONTINUOUS INFUSION; COUGHING; CRITICALLY ILL PATIENT; DELIRIUM; DISEASE CONTROL; DRUG BIOAVAILABILITY; DRUG COST; DRUG DOSE COMPARISON; DRUG DOSE TITRATION; DRUG MECHANISM; DRUG MEGADOSE; DRUG TISSUE LEVEL; DRUG TOLERABILITY; DRUG WITHDRAWAL; ENDOCRINE DISEASE; HEART ARRHYTHMIA; HISTAMINE RELEASE; HUMAN; HYPOTENSION; IMMUNOMODULATION; INTENSIVE CARE UNIT; INTRACRANIAL HYPERTENSION; MUSCLE RIGIDITY; MYOCLONUS; NAUSEA AND VOMITING; NEUROTOXICITY; PAIN; PRIORITY JOURNAL; PRURITUS; RESPIRATION DEPRESSION; REVIEW; SEROTONIN SYNDROME; SIDE EFFECT; UNSPECIFIED SIDE EFFECT; URINE RETENTION; WITHDRAWAL SYNDROME; XEROSTOMIA; ANALGESIA; ARTICLE; CRITICAL ILLNESS; METHODOLOGY;

ANALGESIA; ANALGESICS, OPIOID; CRITICAL ILLNESS; HUMANS; INTENSIVE CARE UNITS; PAIN;

EID: 64749098832     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.08-2264     Document Type: Article

References (77)

1. Brennan F, Carr DB, Cousins M. Pain management: a fundamental human right. Anesth Analg 2007; 105:205-221
2. Jacobi J, Fraser GL, Coursin DB, et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 2002; 30:119-141
3. Beckwith MC, Feddema SS, Barton RG, et al. A guide to drug therapy in patients with enteral feeding tubes: dosage form selection and administration methods. Hosp Pharm
4. 2004; 39:225-237
5. Dickerson RN. Medication administration considerations for patients receiving enteral tube feedings. Hosp Pharm 2004; 39:84-89
6. Australian and New Zealand College of Anaesthetists and Faculty of Pain Medicine. Acute pain management: scientific evidence. Available at: http://www.anzca.edu.au/resources/ books-and-publications. Accessed February 2, 2009
7. American Society of Anesthesiologists Task Force on Acute Pain Management. Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management. Anesthesiology 2004; 100:1573-1581
8. Camu F, Vanlersberghe C. Pharmacology of systemic analgesics. Best Pract Res Clin Anaesthesiol 2002; 16:475-488
9. de Leon-Casasola OA, Lema MJ. Postoperative epidural opioid analgesia: what are the choices? Anesth Analg 1996; 83:867-875
10. Smith MT. Neuroexcitatory effects of morphine and hydromorphone: evidence implicating the 3-glucuronide metabolites. Clin Exp Pharmacol Physiol 2000; 27:524-528
11. Osborne R, Joel S, Grebenik K, et al. The pharmacokinetics of morphine and morphine glucuronides in kidney failure. Clin Pharmacol Ther 1993; 54:158-167
12. Sessler CN, Varney K. Patient-focused sedation and analgesia in the ICU. Chest 2008; 133:552-565
13. Shafer SL, Varvel JR. Pharmacokinetics, pharmacodynamics, and rational opioid selection. Anesthesiology 1991; 74:53-63
14. Metz C, Gobel L, Gruber M, et al. Pharmacokinetics of human cerebral opioid extraction: a comparative study on sufentanil, fentanyl, and alfentanil in a patient after severe head injury. Anesthesiology 2000; 92:1559-1567
15. Shafer A, White PF, Schuttler J, et al. Use of fentanyl infusion in the intensive care unit: tolerance to its anesthetic effects? Anesthesiology 1983; 59:245-248
16. Shibutani K, Inchiosa MA, Sawada K, et al. Pharmacokinetic mass of fentanyl for postoperative analgesia in lean and obese patients. Br J Anaesth 2005; 95:377-383
17. Egan TD, Huizinga B, Gupta SK, et al. Remifentanil pharmacokinetics in obese versus lean patients. Anesthesiology 1998; 89:562-573
18. Richman PS, Baram D, Varela M, et al. Sedation during mechanical ventilation: a trial of benzodiazepine and opiate in combination. Crit Care Med 2006; 34:1395-1401
19. Muellejans B, Lopez A, Cross MH, et al. Remifentanil versus fentanyl for analgesia based sedation to provide patient comfort in the intensive care unit: a randomized, double-blind controlled trial [ISRCTN43755713]. Crit Care 2004; 8:R1-R11
20. Pandharipande PP, Pun BT, Herr DL, et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA 2007; 298: 2644-2652
21. Breen D, Karabinis A, Malbrain M, et al. Decreased duration of mechanical ventilation when comparing analgesia based sedation using remifentanil with standard hypnotic based sedation for up to 10 days in intensive care unit patients: a randomized trial [ISRCTN47583497]. Crit Care 2005; 9:R200-R210
22. Karabinis A, Mandragos K, Stergiopoulos S. Safety and efficacy of analgesia-based sedation with remifentanil versus standard hypnotic-based regimens in intensive care unit patients with brain injuries: a randomised, controlled trial [ISRCTN50308308]. Crit Care 2004; 8:R268-R280
23. Wilhelm W, Kreuer S. The place for short-acting opioids: special emphasis on remifentanil. Crit Care 2008; 12(suppl):S5
24. Bonnet M, Minville V, Asehnoune K, et al. Glycine and ammonia plasma concentrations during sedation with remifentanil in critically ill patients. Intensive Care Med 2007; 33:1179-1182
25. Gurbet A, Goren S, Sahin S, et al. Comparison of analgesic effects of morphine, fentanyl, and remifentanil with intravenous patient-controlled analgesia after cardiac surgery. J Cardiovasc Vasc Anesth 2004; 18:755-758
26. Vinik HR, Kissin I. Rapid development of tolerance to analgesia during remifentanil infusion in humans. Anesth Analg 1998; 86:1307-1311
27. Ranji SR, Goldman LE, Simel DL, et al. Do opiates affect the clinical evaluation of patients with acute abdominal pain? JAMA 2006; 296:1764-1774
28. Whipple JK, Quebbeman EJ, Esser MJ, et al. Current patterns of prescribing and administering morphine in trauma patients? Pharmacotherapy 1995; 15:210-215
29. O'Connor AB, Lang VJ, Quill TE. Underdosing of morphine in comparison with other parenteral opioids in an acute hospital: a quality of care challenge. Pain Med 2006; 7:299-307
30. Hong D, Flood P, Diaz G. The side effects ofmorphine and hydromorphone patient-controlled analgesia. Anesth Analg 2008; 107:1384-1389
31. Eisenberg E, McNicol E, Carr DB. Opioids for neuropathic pain. Cochrane Database Syst Rev (database online). Issue 3, 2006
32. Moore RA, McQuay HJ. Prevalence ofopioid adverse events in chronic non-malignant pain: systematic review ofrandom- ized trials of oral opioids. Arthritis Res Ther 2005; 7:R1045R1051
33. Cherny N, Ripamonti C, Pereira J, et al. Strategies to manage the adverse effects of oral morphine: an evidence based report. J Clin Oncol 2001; 19:2542-2554
34. Hung OR, Bands C, Laney G, et al. Drug allergies in the surgical population. Can J Anaesth 1994; 41:1140-1155
35. Ehret GB, Voide C, Gex-Fabry M, et al. Drug-induced long QT syndrome in injection drug users receiving methadone. Arch Intern Med 2006; 166:1280-1287
36. Forrest WH, Brown BW, Brown CR, et al. Dextroamphetamine with morphine for the treatment of postoperative pain. N Engl J Med 1977; 296:712-715
37. Armstrong SC, Cozza KL. Pharmacokinetic drug interactions of morphine, codeine, and their derivatives: theory and clinical reality; part I. Psychosomatics 2003; 44:167-171
38. Pandey CK, Raza M, Ranjan R, et al. Intravenous lidocaine suppresses fentanyl-induced coughing: a double-blind, prospective, randomized placebo-controlled study. Anesth Analg 2004; 99:1696-1698
39. Yu H, Yang XY, Zhang X, et al. The effect of dilution and prolonged injection time on fentanyl-induced coughing. Anesthesia 2007; 62:919-922
40. Daniel HW. Opioid endocrinopathy in women consuming prescribed sustained-action opioids for control of nonmalignant pain. J Pain 2008; 9:28-36
41. Oltmanns KM, Fehm HL, Peters A. Chronic fentanyl application induces adrenocortical insufficiency. J Intern Med 2005; 257:478-480
42. White IK, Hoskin PJ, Hanks GW, et al. Morphine and dryness of the mouth. BMJ 1989; 298:1222-1223
43. Moss J, Rosow CE. Histamine release by narcotics and muscle relaxants in humans. Anesthesiology 1983; 59:330-339
44. Doenicke A, Moss J, Lorenz W, et al. Intravenous morphine and nalbuphine increase histamine and catecholamine release without accompanying hemodynamic changes. Clin Pharmacol Ther 1995; 58:81-89
45. Bonnet MP, Beloeil H, Benhamou D, et al. The μ opioid receptor mediates morphine-induced tumor necrosis factor and interleukin-6 inhibition in toll-like receptor 2-stimulated monocytes. Anesth Analg 2008; 106:1142-1149
46. Zaborina O, Lepine F, Xiao G, et al. Dynorphin activates quorum sensing quinolone signaling in Pseudomonas aeruginosa. PLoS Pathog 2007; 3:e35
47. Brain Trauma Foundation. XI: anesthetics, analgesics, and sedatives. J Neurotrauma 2007; 24(suppl):S71-S76
48. Lauer KK, Connolly LA, Schmeling WT. Opioid sedation does not alter intracranial pressure in head injured patients. Can J Anaesth 1997; 44:929-933
49. de Nadal M, Munar F, Poca MA, et al. Cerebral hemodynamic effects of morphine and fentanyl in patients with severe head injury. Anesthesiology 2000; 92:11-19
50. Potter JM, Reid DB, Shaw RJ, et al. Myoclonus associated with treatment of high doses of morphine: the role of supplemental drugs. BMJ 1989; 299:150-153
51. 3 antagonists? Br J Anaesth 1999; 82:439-441
52. Gillman PK. Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity. Br J Anaesth 2005; 95:434-441
53. Rosow CE, Gomery P, Chen TY, et al. Reversal of opioid induced bladder dysfunction by intravenous naloxone and methylnaltrexone. Clin Pharmacol Ther 2007; 82:48-53
54. Thomas J, Karver S, Austin Cooney G, et al. Methylnaltrexone for opioid-induced constipation in advanced illness. N Engl J Med 2008; 358:2332-2343
55. Moss J, Rosow CE. Development of peripheral opioid antagonists: new insights into opioid effects. Mayo Clin Proc 2008; 83:1116-1130
56. Relistor [package insert]. Tarrytown, NY: Progenics Pharmaceuticals, 2008
57. Entereg [package insert]. Exton, PA: Adolor Corporation, 2008
58. Brill S, Ginosar Y, Davidson EM. Perioperative management of chronic pain patients with opioid dependency. Curr Opin Anaesthesiol 2005; 19:325-331
59. Alford DP, Compton P, Samet JH. Acute pain management for patients receiving maintenance methadone or buprenorphine therapy. Ann Intern Med 2006; 144:127-134
60. Patanwala AE, Duby J, Waters D, et al. Opioid conversions in acute care. Ann Pharmacother 2007; 41:255-266
61. Challapalli V, Tremont-Lukats IW, McNicol ED, et al. Systemic administration of local anesthetic agents to relieve neuropathic pain. Cochrane Database Syst Rev (database online). Issue 4, 2005
62. Wiffen P, Collins S, McQuay H, et al. Anticonvulsant drugs for acute and chronic pain. Cochrane Database Syst Rev (database online). 2008; CD001133
63. Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database Syst Rev (database online). Issue 4, 2007
64. Marret E, Kurdi O, Zufferey P, et al. Effects of nonsteroidal anti-inflammatory drugs on patient-controlled analgesia morphine side effects. Anesthesiology 2005; 102:1249-1260
65. Remy C, Marret E, Bonnet F. Effects of acetaminophen on morphine side-effects and consumption after major surgery: meta-analysis of randomized controlled trials. Br J Anaesth 2005; 94:503-513
66. Bertolini G, Minelli C, Latronico N, et al. The use of analgesic drugs in postoperative patients: the neglected problem of pain control in intensive care units; an observational, prospective, multicenter study in 128 Italian intensive care units. Eur J Clin Pharmacol 2002; 58:73-77
67. 65a. Puntillo K, Pasero C, Li D, et al. Evaluation of pain in ICU patients. Chest 2009; 135:1069-1074
68. Melzack R, Wall P. Pain mechanisms: a new theory. Science 1965; 150:971-978
69. Keefe' F. Can cognitive-behavioral therapies succeed where medical treatments fail? In: Devor M, Rowbotham MC, Wiesenfeld-Hallin, eds. Proceedings of the 9th World Congress on pain, progress in pain research and management. Seattle, WA: IASP Press, 2000; 1069-1084
70. Mobily PR. Nonpharmacologic interventions for the management of chronic pain in older women. J Women Aging 1994; 6:89-109
71. Cepeda MS, Carr DB, Lau J, et al. Music for pain relief. Cochrane Database Syst Rev (database online). Issue 2, 2006
72. McCaffery M, Beebe A. Pain: clinical manual for nursing practice. St. Louis, MO: CV Mosby, 1989
73. Kwekkeboom KL, Gretarsdottir E. Systematic review of relaxation interventions for pain. J Nurs Scholarsh 2006; 38:269-277
74. Good M, Stanton-Hicks M, Grass JA, et al. Relief of postoperative pain with jaw relaxation, music and their combination. Pain 1999; 81:163-172
75. Royjulcharoen V, Good M. Systematic relaxation to relieve postoperative pain. J Adv Nurs 2004; 48:140-148
76. Gavito MC, Ledezma P, Moales J, et al. Effect of induced relaxation on pain and anxiety in thoracotomized patients. Salud Mental 1999; 22:24-27
77. Suls J, Wan CK. Effects of sensory and procedural information on coping with stressful medical procedures and pain: a meta-analysis. J Consult Clin Psychol 1989; 57:372-379